Clinical Trials Logo

Clinical Trial Summary

The most common forms of injection used for the treatment of degenerative lumbar spinal stenosis (DLSS) patients with neurogenic claudication (NC) are the caudal and inter-laminar epidural injections of anesthetic and steroid. Unilateral transforaminal epidural steroid injections (TESI) are also used to alleviate patients' symptoms of NC from DLSS, particularly in patients whose level of stenosis is L4-5 or higher. However, these unilateral injections do not cross the midline, so in cases of lower extremity pain and symptoms on both sides, a bilateral TESI would probably be more beneficial.

To date, there have not been any well designed prospective studies to determine the effectiveness of bilateral TESI below the level of stenosis in DLSS patients with NC. Therefore, the goal of this prospective, non-randomized case-series outcome study is to evaluate the effectiveness of BTESI in alleviating symptoms of NC, as well as improving function in patients with DLSS. The hypothesis is that BTESI at the level below the most stenotic segment of the central canal of the lumbar spine decreases symptoms of NC and improves function in patients with DLSS.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT01995461
Study type Interventional
Source Marshfield Clinic Research Foundation
Contact
Status Terminated
Phase N/A
Start date May 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT03863067 - Clinical Effectiveness, Security And Radiological Changes In Epiduroscopy For Lumbar Stenosis N/A
Completed NCT02093520 - The MiDAS ENCORE Study N/A
Active, not recruiting NCT03610737 - The MOTION Study - Treatment of LSS With the MILD Procedure N/A